Smarter population management,
immediate revenue impact
Validated on 2.8 million patient records within a leading national HMO, with live clinical pilots across EU markets. Medāna gives hospitals and health maintenance organizations full visibility over their population’s health risks. Harmonize your data across departments and systems, identify high-risk patients earlier, reduce unnecessary hospitalizations, and recover revenue lost to coding gaps, claim denials, and billing errors
Our AI models predict chronic disease years before diagnosis, including genomic risk markers, so your teams can intervene before conditions escalate
See the risk before it becomes a claim
Move from reactive claims processing to proactive risk management. Medāna provides real-time risk assessment and cost optimization through predictive analytics, helping insurers identify high-cost members earlier, optimize actuarial models with genomic risk data, and reduce claims through targeted prevention programs. Better predictions mean fewer surprises
AI-ready data for faster discovery
Access high-quality, annotated clinical and genomic datasets for drug discovery, clinical trial acceleration, and real-world evidence generation. Medāna enables rapid cohort identification and eligibility screening across diverse populations, with synthetic control arms, genomic stratification, and longitudinal outcome tracking, all within a compliant, privacy-preserving framework
Turn sequencing data into clinical impact
Sequencing labs and direct-to-consumer genomics companies generate massive volumes of genetic data, but translating it into clinical action requires integration with real-world health records and clinical algorithms. Medāna bridges this gap: integrating genetic data with clinical trajectories, deploying polygenic risk scores at population scale and powering screening programs that connect genetic insights to preventive care pathways
